The history and dynamics of the access to medicines debate provide a number of reflections for those concerned with protecting farmers’ access to seeds. Taking the Doha Declaration on TRIPS and Public Health as its point of departure, this paper explores implications for interested parties at the international and national levels, as well as for multilateral institutions themselves.

Three lessons stand out in particular.